Literature DB >> 1738745

Acute pyelonephritis. Preventing complications through prompt diagnosis and proper therapy.

S M Tenner1, M W Yadven, P L Kimmel.   

Abstract

The diagnosis of pyelonephritis is based on clinical and laboratory criteria that include fever, flank pain or tenderness, leukocytosis, pyuria, and confirmatory urine culture. A Gram stain of unspun urine can provide an important early clue regarding the etiologic agent. At least 85% of cases are caused by Escherichia coli, but clinicians need to be aware of other potentially aggressive organisms as well. Elderly, diabetic, or immunocompromised hospitalized patients and patients subject to instrumentation present a more complex diagnostic challenge and require more intense parenteral treatment. Prompt diagnosis and proper therapy decrease the risk of serious complications.

Entities:  

Mesh:

Year:  1992        PMID: 1738745     DOI: 10.1080/00325481.1992.11701211

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  4 in total

1.  Novel biomarkers for the diagnosis of urinary tract infection-a systematic review.

Authors:  Neha Nanda; Manisha Juthani-Mehta
Journal:  Biomark Insights       Date:  2009-08-05

2.  Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.

Authors:  Seung-Kwan Lim; In Whee Park; Wee Gyo Lee; Hyun Kyung Kim; Young Hwa Choi
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

3.  Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.

Authors:  Justyna Bien; Olga Sokolova; Przemyslaw Bozko
Journal:  Int J Nephrol       Date:  2012-03-08

4.  Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis.

Authors:  Arianna Pompilio; Valentina Crocetta; Vincenzo Savini; Dezemona Petrelli; Marta Di Nicola; Silvia Bucco; Luigi Amoroso; Mario Bonomini; Giovanni Di Bonaventura
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.